F-group (family)
2003.1.4.1 TPP_enzyme_M
Ligands and drugs
1,004
Member domains
483
with ligand contacts (≤ 4 Å)
48.1% of members
352
with DrugDomain annotations
35.1% of members
288
with a DrugBank compound
28.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.4.1 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | Flavin adenine dinucleotide | 175 |
| DB16833 | ADP | Adenosine disphosphate | 32 |
| DB00119 | PYR | Pyruvic acid | 20 |
| DB02280 | RMN | (R)-Mandelic acid | 16 |
| DB03309 | NHE | N-cyclohexyltaurine | 12 |
| DB04447 | DTT | 1,4-Dithiothreitol | 10 |
| DB14475 | 2OP | L-Lactic acid | 4 |
| DB03656 | 1TB | Tribenuron Methyl | 3 |
| DB01694 | TAR | D-tartaric acid | 2 |
| DB01992 | COA | Coenzyme A | 2 |
| DB02676 | B3P | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | 2 |
| DB03531 | FAB | Flavin-adenine dinucleotide-N5-isobutyl ketone | 2 |
| DB03884 | PPY | Phenylpyruvic acid | 2 |
| DB08050 | KPV | 5-phenyl-2-keto-valeric acid | 2 |
| DB08689 | UQ1 | Ubiquinone Q1 | 2 |
| DB01692 | DTU | Dithioerythritol | 1 |
| DB03578 | PYM | Pyruvamide | 1 |
| DB04582 | 1IQ | Imazaquin | 1 |
| DB09459 | TLA | L-tartaric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 213 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 84 |
| Kmetal | POTASSIUM ION | 29 |
| UQ0 | 2,3-DIMETHOXY-5-METHYL-1,4-BENZOQUINONE | 24 |
| CL | CHLORIDE ION | 21 |
| MGmetal | MAGNESIUM ION | 20 |
| RMN | (R)-MANDELIC ACID | 16 |
| 60G | methyl 2-[(4,6-dimethoxypyrimidin-2-yl)carbamoylsulfamoylmethyl]benzoate | 15 |
| TPP | THIAMINE DIPHOSPHATE | 15 |
| PYR | PYRUVIC ACID | 14 |
| FYN | S-{(9R,13S,15R)-17-[(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3-(PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]-9,13,15-TRIHYDROXY-10,10-DIMETHYL-13,15-DIOXIDO-4,8-DIOXO-12,14,16-TRIOXA-3,7-DIAZA-13,15-DIPHOSPHAHEPTADEC-1-YL} THIOFORMATE | 13 |
| NHE | 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID | 12 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 10 |
| UQ3 | S-{(3S,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5,10,14-tetraoxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} (2R)-2-hydroxypropanethioate | 8 |
| 3KK | S-{(3R,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} 2-hydroxy-2-methylpropanethioate | 6 |
| CIE | 2-[[[[(4-CHLORO-6-METHOXY-2-PYRIMIDINYL)AMINO]CARBONYL]AMINO]SULFONYL]BENZOIC ACID ETHYL ESTER | 6 |
| DW3 | 2-oxidanylethanal | 6 |
| PXD | 2-(2,2-difluoroethoxy)-N-(5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)-6-(trifluoromethyl)benzenesulfonamide | 6 |
| PY0 | (1S,2S)-1-amino-1,2-dihydroxypropan-1-olate | 6 |
| TDK | 3-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-2-{(1S)-1-HYDROXY-1-[(R)-HYDROXY(METHOXY)PHOSPHORYL]ETHYL}-5-(2-{[(S)-HYDROXY(PHOSPHONOOXY)PHOSPHORYL]OXY}ETHYL)-4-METHYL-1,3-THIAZOL-3-IUM | 6 |